GLP-1RA use was defined as having an active prescription for either semaglutide, dulaglutide, liraglutide, or tirzepatide in the electronic medical record
Importantly, the nuance in offering GLP-1s is that employers want to ensure they get into the hands of the employees that stand to benefit most and thus get the most value out of the medicines, so I expect we will see additional restrictions put in place to control coverage of these medicines, in the form of prior authorizations and other controlled access
Possible monitoring points include injection site reactions, swelling, joint discomfort, muscle aches, numbness or tingling, blood sugar changes, or fluid retention
Wonderful staff and service
affordable yet effective options abound, but investing in trusted ones yields better results
What Else to Know About Midi's GLP-1s GLP-1s arent quick fix solutionsand at Midi, we strongly believe in safe, sustainable weight loss